Islam, Kendall B.
Brandman, Danielle
Chu, Janet N.
Goldman, Max L.
Fox, Rena K. http://orcid.org/0000-0002-9883-3603
Funding for this research was provided by:
Gilead Sciences (IN-US-989-5737)
Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
NIH (T32HP19025T-32)
Article History
Received: 28 March 2022
Accepted: 19 September 2022
First Online: 30 September 2022
Declarations
:
: Dr. Brandman has received research support from Allergan, Conatus, and Grifols, and grant and research support from Gilead. She has served on an advisory board and consulted for Alnylam.
: This study was reviewed and approved by the UCSF Institutional Review Board.